Could home blood tests transform hemophilia care? study seeks patient views

NCT ID NCT06702579

Knowledge-focused Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how patients with hemophilia A or those on blood thinners feel about monitoring their blood clotting at home. Researchers interviewed 19 people to understand their needs and hopes for a new device that could measure clotting factors. The goal was to gather insights to guide future home monitoring tools, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to: If successful, this could help design home monitoring devices that make hemophilia care easier and give patients more independence.
What could go wrong: This is a small, terminated observational study with only 19 participants, so findings may not apply broadly. No treatment is being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

19 people

The number who actually took part.

Started

Oct 2024

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The exact sample size for this study is not predetermined. Instead, patients will be selected using purposeful sampling methodology until theoretical saturation is achieved. Maximum variation in age, severity of hemophilia and received treatment will be pursued. Three cases are included in the study: 1. Patients registered at the "Trombosezorg dichterbij", treated with a vitamin K antagonist for any indication, currently engaging in self-testing INR at home 2. Patients and caregivers of patients with hemophilia A, who require prophylactic therapy with a factor VIII concentrate. Hemophilia patients will be sampled from the patients receiving care from the Hemophilia Treatment Center Nijmegen Eindhoven Maastricht. If insufficient patients can be included from this population to achieve data saturation, additional patients will be sampled via the patient society 3. HCPs involved in the treatment of hemophilia patients and technical experts to provide additional context.

Ages

12 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patients treated with vitamin K antagonists Inclusion criteria * Aged \> 16 years * Patient using vitamin K antagonist for any indication * Registered at the "Trombosezorg dichterbij" * Self-testing INR at home for \> 3 months * A history of monitoring INR at a care facility (not self-testing) * Signed informed consent form * Able to speak and understand Dutch or English without a translator Exclusion criteria • Unwilling to consent with the study or with audio recording Hemophilia A patients Inclusion criteria * Diagnosis of congenital hemophilia A, with or without inhibitors * Receiving prophylactic treatment * Patients aged ≥ 12 years or caregivers of patients aged \< 12 years old * Signed informed consent form * Able to speak and understand Dutch or English without a translator Exclusion criteria * No diagnosis of congenital hemophilia A * Unwilling to consent with the study or with audio recording Hemophilia healthcare professionals Inclusion criteria * Hematologist, hemophilia nurse, pharmacist or healthcare provider currently involved in the care for patients with hemophilia * At least \> 3 years clinical experience in hemophilia care * Signed informed consent form * Able to speak and understand Dutch or English without a translator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anticoagulant therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemophilia A

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anticoagulant therapy Hemophilia A Monitoring Point of care testing Qualitative research

Could home blood tests transform hemophilia care? study seeks patient views

What the study statuses mean